Diagnosing cerebral palsy isn’t a single test — it’s a coordinated set of assessments that together build the clinical picture. Knowing what each test measures, when it’s used, and how the pieces connect helps families understand what’s happening as a workup unfolds.
Parents working through a cerebral palsy workup often see a long list of recommended tests and wonder how they connect. The truth is that no single test diagnoses CP — the clinical picture comes together from many sources: the developmental history, the neurological exam, standardized assessments, brain imaging, and sometimes genetic testing. This guide is a field guide to the full toolkit: what each test measures, when it’s used, and how the pieces fit together.
For the umbrella view of how cerebral palsy is diagnosed, see the parent guide. For the structured criteria that define a CP diagnosis, see cerebral palsy diagnostic criteria. This page focuses specifically on the tests themselves — what each one does and how it contributes.
Catching CP early starts with consistent surveillance — well-child visits, standardized screening, and parental observation. The earliest indicators are subtle, but they cluster in recognizable patterns that experienced clinicians can identify.
The detection process is layered. Pediatricians monitor development at routine visits, parents observe behavior at home, and standardized tools systematize what would otherwise be subjective impression. When concerns cluster across these layers, formal evaluation begins.
The patterns that prompt screening or referral:
For a fuller walkthrough of what to watch for in the first year, see our deeper guide on early signs of cerebral palsy in infants.
Milestones are the structured framework for tracking development:
Milestone delays alone don’t diagnose CP, but they’re the most common entry point into the workup. A child consistently delayed across multiple motor milestones — especially with the qualitative concerns above — is the typical referral profile.
Screening combines hands-on motor assessment with imaging when concerns arise. Each method answers a different question, and the right combination depends on the child’s age, history, and presenting concerns.
Screening is broader than testing for CP specifically — it’s structured developmental surveillance that catches a range of concerns. The tools below are the ones most relevant when CP is on the differential.
The standardized assessments most commonly used:
The GMA and HINE are the two most CP-specific tools. They’re used routinely in major neurodevelopmental follow-up clinics and increasingly in community settings.
Imaging confirms what clinical assessment suggests. Each modality has specific uses:
For a comprehensive look at how MRI specifically contributes to CP diagnosis, see our dedicated guide on the role of MRI in cerebral palsy diagnosis.
A typical screening evaluation combines:
When initial screening identifies concerns, more specific diagnostic tests confirm the picture. Diagnostic tests aren’t fundamentally different from screening tools — they’re often the same tools used at greater depth, plus additional modalities like genetic testing and physical therapy evaluation.
The line between screening and diagnostic isn’t always sharp. A pediatrician’s ASQ at a well-child visit is a screening tool; a pediatric neurologist’s HINE done after a referral is a diagnostic tool, even though both can use similar standardized scales. What matters is the depth, the expertise of the clinician, and whether the goal is to detect concerns (screening) or characterize what’s happening (diagnostic).
Genetic testing has moved from research curiosity to clinical option for many CP cases. When it’s used:
The most common test is whole-exome sequencing (WES), often combined with chromosomal microarray. For when, why, and how genetic testing fits into the diagnostic workup, see our dedicated guide on genetic testing for cerebral palsy.
Physical therapy evaluations contribute essential functional information:
PT evaluations typically happen alongside the medical workup rather than after diagnosis is finalized. Most children with motor concerns are referred to PT before the diagnostic picture is fully clear — therapy doesn’t need to wait for confirmation. For more on how PT fits into ongoing care, see physical therapy for cerebral palsy.
Screening matters because it’s the gatekeeper to early intervention. Catching concerns early opens access to therapy, supports, and resources during the developmental window when they have the biggest impact.
The case for routine screening is straightforward: brain plasticity is highest in the first three years, therapy works best during that window, and early-intervention services are most accessible when concerns are identified during infancy. Every layer of screening — well-child visits, parental observation, standardized tools, specialist evaluation — raises the chances that concerns reach a clinician’s attention while there’s still time to act.
What therapy actually accomplishes when started early:
For a deeper look at why timing matters so much, see our dedicated guide on the importance of early diagnosis in cerebral palsy.
Knowing which infants are at higher risk shapes how aggressively to screen:
Babies in any of these categories are typically followed in neurodevelopmental clinics with more intensive screening than routine pediatric care provides.
One of the most important things to understand about CP screening: pediatricians and specialists refer to therapy and additional evaluation based on concerns, not certainty. A child doesn’t need to clearly have CP for screening to be useful — the goal is to catch developmental issues whose diagnosis might still be unfolding. Most children referred for early intervention or specialist evaluation don’t end up with a CP diagnosis. Catching the ones who do, early enough for therapy to help, is what makes the system work.
Failure to perform standardized developmental screening at recommended ages, missed cluster of risk factors, or delays in referring to specialists when concerns arise can lead to delayed CP diagnosis and missed therapy windows. When delays cause measurable harm, families sometimes have legal options to recover the cost of intensified care. Our birth injury lawyers review screening histories alongside delivery records. Request a free case review.
Our nurse advocates can walk through what testing has been done, what might still be appropriate, and connect you with specialists in your area. Get a free, confidential evaluation.
Cerebral palsy screening combines several assessment types: physical and neurological exams (muscle tone, reflexes, posture), standardized developmental tools (Ages and Stages Questionnaires, Bayley Scales), specialized infant assessments (General Movements Assessment, Hammersmith Infant Neurological Examination), brain imaging (MRI, cranial ultrasound), and sometimes genetic testing. No single test diagnoses CP — they work together to build the clinical picture.
Early diagnosis combines vigilant developmental monitoring at well-child visits, standardized screening at recommended ages (9, 18, 24 months), specialized assessments for high-risk infants, and brain imaging when concerns arise. Pediatricians refer to neurology when motor or developmental concerns cluster, and pediatric neurologists make the formal diagnosis. The process typically spans months as the clinical picture clarifies.
Early screening matters because the brain is most plastic in the first three years — therapy started during that window builds motor and cognitive skills more effectively than later therapy. Early screening also opens access to early-intervention services, supports educational planning before academic demands intensify, and gives families time to adjust and access resources before they’re urgently needed.
All children should receive standardized developmental screening at 9, 18, and 24 or 30 months, per AAP guidelines. High-risk infants — preemies, NICU graduates, babies with HIE, complicated deliveries — should be enrolled in specialized neurodevelopmental follow-up clinics from the start. Any infant or child showing motor concerns, missed milestones, or unusual muscle tone should be evaluated promptly regardless of age.
Screening tests catch CP early enough to make therapy maximally effective. They distinguish CP from look-alike conditions, support insurance approvals for therapy, document developmental concerns for school-based services, and can identify treatable conditions previously missed. Screening also gives families clearer information earlier, which reduces uncertainty and supports informed decision-making.
Costs vary widely. Standard developmental screening at well-child visits is usually included in routine pediatric care. Brain MRI typically runs $1,000 to $3,000 before insurance. Genetic testing can range from $500 (chromosomal microarray) to $5,000 (whole-exome sequencing) before insurance. Most insurance plans cover medically indicated tests — pre-authorization is common but coverage is usually approved when criteria are met. Early-intervention services for kids under 3 are typically free or low-cost regardless of family income.
Kelsey is an experienced surgical nurse with more than 10 years in hospital-based care, including leadership within the operating room. She has worked extensively with pediatric patients, refining her ability to support children and families during critical moments. As both a mentor and patient advocate, Kelsey is dedicated to promoting safety, communication, and compassionate care while helping families understand medical procedures, treatment options, and the realities surrounding birth injuries and pediatric conditions.
Our nurses, patient advocates and legal experts are solely focused on bringing you the latest cerebral palsy information, options for financial assistance and access to community support.
Editorial process →